Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-22
2008-04-22
Andres, Janet L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S461000, C549S501000, C548S377100
Reexamination Certificate
active
07361679
ABSTRACT:
The present invention relates to a 2-phenyl-3-heteroarylpropionic acid derivative or a salt thereof, and also relates to a pharmaceutical agent and a VLA-4 and/or LPAM-1 antagonist each of which contains the same as an active ingredient.
REFERENCES:
patent: 0293220 (1988-05-01), None
patent: 293220 (1988-11-01), None
patent: 1097596 (1968-01-01), None
patent: WO 98/08840 (1998-03-01), None
patent: WO 99/06433 (1999-02-01), None
patent: WO 99/62901 (1999-12-01), None
patent: WO 99/64390 (1999-12-01), None
Hcaplus 78:58183.
Durant et. al., “Nonsteroidal Antiinflammatory Agents. Some Arylacetic Acids”, Journal of Medicinal Chemistry (1965), 8(5), 598-603.
Hcaplus 143:95268.
Lobb et. al., “Small molecule antagonists of alpha 4 integrins: novel drugs for asthma”, Expert Opinion on Investigational Drugs (1999) 8(7):935-945.
Hoshina Yoichiro
Ikegami Satoru
Andres Janet L.
Kaken Pharmaceutical Co. Ltd.
Nixon & Peabody LLP
Robinson Binta
LandOfFree
2-phenyl-3-heteroarylpropionic acid derivative or salt... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-phenyl-3-heteroarylpropionic acid derivative or salt..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-phenyl-3-heteroarylpropionic acid derivative or salt... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2776291